Astragalus for Health & Longevity - Quick Reference Sheet
evipedia.aidev
← Back

Astragalus for Health & Longevity

Created on 08/14/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4.5 – Audit

Astragalus is a traditional root tonic whose longevity use depends on the product. A purified extract lengthens white-cell chromosome end-caps without matching strength, walking, or inflammation gains. Add-on blood-sugar, kidney, and heart results are weaker. Oral use is mostly limited by nausea and stomach discomfort. Autoimmune disease, transplant drugs, pregnancy, allergy, and unsupervised injection sit on the avoid list. (Full Review)

Protocol

Standardized oral extract
250–500 mg, one to three times daily
Labels vary by extraction ratio; follow stated astragaloside IV content when disclosed
TA-65 / cycloastragenol
About 8–16 mg/day or 250–1,000 U
Sometimes split; nanomolar plasma levels after single 10–50 mg doses
Time of day
Morning
Traditional tonic timing; no circadian outcome trial exists. Split doses are reasonable
Time to effect
Telomere change
3–12 months
White-cell chromosome end-caps in extract trials
Glucose and kidney markers
Weeks to a few months
Usual window for add-on metabolic and kidney-marker trials
Immune markers and symptoms
4–12 weeks
Typical window for immune-marker and symptom trials

Benefits

Contraindications
  • Autoimmune disease (systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease)
  • Solid-organ or hematopoietic transplant, or current calcineurin-inhibitor immunosuppression
  • Pregnancy and lactation
  • Known allergy to Astragalus or its polysaccharide extracts
  • Unsupervised use of intravenous Huangqi injection outside a regulated clinical setting
    •
Key Interactions
  • Immunosuppressants (cyclosporine, tacrolimus, mycophenolate, high-dose corticosteroids)
  • Lithium
  • Glucose-lowering drugs (metformin, sulfonylureas, insulin, SGLT2 inhibitors)
  • Antihypertensives (ACE inhibitors (lisinopril), ARBs (losartan), amlodipine, hydrochlorothiazide)
  • Other immune stimulants (echinacea, medicinal mushrooms, beta-glucans)
  • Glucose- and pressure-lowering supplements (berberine, cinnamon, hawthorn, beetroot)
  • Chemotherapy (anthracyclines (doxorubicin), cyclophosphamide)
  • Over-the-counter NSAIDs (ibuprofen, naproxen, aspirin)
    •

Risk & Side Effects

  • High:
  • Medium: Gastrointestinal intolerance
    •
  • Low: Hypersensitivity reactions; Autoimmune disease worsening
    •
  • Speculative: Telomerase-related tumor promotion; Fetal toxicity
    •

Monitoring

Marker Target Why
Fasting glucose 70–85 mg/dL (3.9–4.7 mmol/L) Tracks add-on glucose lowering
HbA1c 4.8–5.3% 90-day glucose exposure
hs-CRP <0.7 mg/L Inflammation; TA-65 secondary endpoint
eGFR >90 mL/min/1.73 m² Kidney filter function
Urine albumin–creatinine ratio <10 mg/g Early kidney protein leak
ALT <25 U/L (women), <30 U/L (men) Liver safety
Sitting and standing blood pressure 110–120 / 70–80 mmHg Additive pressure lowering
CBC with differential Track change from own baseline Lymphocyte remodeling; allergy signal

Cadence: Baseline; repeat at 4–8 weeks, again at 3–6 months, then every 6–12 months if use continues. Matching drug-level or disease-activity checks on that cadence for lithium, insulin, or anti-rejection or immune-suppressing drugs

Qualitative Assessment

  • Energy and recovery after ordinary training or illness
  • Infection frequency and duration across a season
  • Gastrointestinal comfort after each dose
  • Joint, skin, or neurologic symptoms that could signal immune over-activation
  • For branded saponin use: whether any telomere report is accompanied by a real-world function change
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.